The CFAR Molecular Diversity Core was initiated in 1995 to provide a DNA sequencing service to support the AIDS research community. It evolved into the current Genomics Core with a new focus on providing assistance in assuring HIV sequence quality control and in performing detailed phylogenetic and bioinformatic analyses. Since its inception, the Core has contributed to ten or more collaborative, peerreviewed publications per year. Going forward, we will continue to develop, refine, implement, support and teach methods for the study of HIV gene sequences. However, we will also broaden the scope of the core in ways that together make Computational Biology, rather than Genomics, the most apt description of our new Core. First, we will create an open-source bioinformatics toolkit that includes incorporation of existing analytical tools together with emerging techniques. This toolkit is being developed in collaboration with the local CFAR Biostatistics Core, the Los Alamos National Laboratory (LANL) and investigators at the UCSD CFAR. Second, we will expand our efforts at training and research community outreach. To this end we will develop a unified web-based interface to access our analysis tools, using questionnaires to determine need for tool development and training sessions. We will develop an easier mechanism for users to ask specific questions or request specific support for both existing tool usage and possibly additional novel analyses. Lastly, we will produce a regular Newsletter to inform the CFAR community of the availability and functionality of our computational tools and similar programs from other sources. Third, our CFAR efforts will link and assist parallel and separately funded efforts to develop a database to acquire, retain and mine clinical, laboratory and genetic data derived from HIV and infected human hosts. These database and mining tools are being developed, implemented and will be spread to investigators throughout the international CFAR community and other AIDS researchers. Development is proceeding through collaboration with all of the major laboratories gathering viral gene sequence data, leaders of those gathering AIDS-related clinical, therapy, host genetics and viral immunology data, as well as those leading in the area of integrated data analysis. These include investigators at the UW, LANL, six CFARs that focus on a combination of these areas, as well as the Multicenter AIDS Cohort Study (MACS), the Center for HIV-AIDS Vaccine Immunology (CHAVI), and the Collaborative AIDS Vaccine Discovery (CAVD) and Partners in Prevention (PIP) programs funded by the Bill and Melinda Gates foundation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-25
Application #
8376323
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
25
Fiscal Year
2012
Total Cost
$288,952
Indirect Cost
$112,545
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wagner, Anjuli D; O?Malley, Gabrielle; Firdawsi, Olivia et al. (2018) Brief Report: Disclosure, Consent, Opportunity Costs, and Inaccurate Risk Assessment Deter Pediatric HIV Testing: A Mixed-Methods Study. J Acquir Immune Defic Syndr 77:393-399
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
LaCourse, Sylvia M; Cranmer, Lisa M; Njuguna, Irene N et al. (2018) Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children. Clin Infect Dis 66:1798-1801
Golovaty, Ilya; Sharma, Monisha; Van Heerden, Alastair et al. (2018) Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa. J Acquir Immune Defic Syndr 78:522-526
Torres, Thiago S; Harrison, Linda J; La Rosa, Alberto M et al. (2018) Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS 32:583-593
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Patel, Rena C; Bukusi, Elizabeth A; Baeten, Jared M (2018) Current and future contraceptive options for women living with HIV. Expert Opin Pharmacother 19:1-12
Ross, Jennifer M; Ying, Roger; Celum, Connie L et al. (2018) Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs. Epidemics 23:34-41
Wagner, Anjuli D; Shah, Seema K; Njuguna, Irene N et al. (2018) Financial Incentives to Motivate Pediatric HIV Testing-Assessing the Potential for Coercion, Inducement, and Voluntariness. J Acquir Immune Defic Syndr 78:e15-e18
Stekler, Joanne D; Milne, Ross; Payant, Rachel et al. (2018) Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort. PLoS Med 15:e1002537

Showing the most recent 10 out of 1275 publications